HOME >> MEDICINE >> NEWS
Stanford study shows now-familiar medications at core of better outlook for depressed patients

STANFORD, Calif. - Enough Americans suffer from depression to fill Yankee Stadium 330 times over, and while depression rates continue to rise, people with the illness have reason to be hopeful. A new study shows that doctors are treating the disease more than ever before - thanks in part to the newest category of antidepressant medication.

"Our study confirms the belief that the diagnosis and treatment of depression have been impacted by the advent of selective serotonin reuptake inhibitors (SSRIs)," said Randall Stafford, MD, assistant professor of medicine at Stanford University School of Medicine and lead author of the latest report. "Findings show that the quality of care received by depressed patients has improved since the introduction of this class of medications in 1988." The study appeared in the April 29 issue of the Primary Care Companion to the Journal of Clinical Psychiatry.

SSRIs are one of several categories of antidepressants. Although medications in each category are effective in treating the disease, SSRIs (including well-known brands such as Prozac, Paxil and Zoloft) have fewer side effects than the others. Stafford noted that patients who take other types also face a greater risk of overdose, along with more side effects such as weight gain, stomach irritation and dry mouth.

The safety profile and relatively limited side effects of SSRIs make them attractive to both physicians and patients, Stafford said, and as a result they are the most prescribed category of antidepressant in the country. Stafford's team conducted the study to examine the drugs' popularity among physicians and to more closely examine their impact on treatment of depressive illness.

"Past studies have focused on broader changes in depression treatment, but we wanted to go beyond this and look at the relationship between SSRIs and other medications," he said. "There was a perception that treatment had changed since the advent of SSR
'"/>


29-Apr-2002


Page: 1 2 3

Related medicine news :

1. Stanford patient is first to test new treatment for peripheral arterial disease
2. Protein that helps skin cancer spread identified by Stanford researchers
3. Computer model being developed at Stanford may help surgeons better predict patient outcomes
4. Brain-scanning technologies need standards, according to Stanford researcher
5. Young blood revives aging muscles, Stanford researchers find
6. Brain synapse formation linked to proteins, Stanford study finds
7. Early HIV screening prolongs life and is affordable, Stanford study shows
8. Vioxx went mostly to patients who didnt need it, Stanford researcher says
9. Stanford study shows hypnosis helps kids undergoing difficult procedure
10. Ethics of neuroimaging research to be focus of NIH/Stanford meeting
11. Early learning leaves lasting changes in brain, Stanford owl study shows

Post Your Comments:
(Date:3/2/2015)... Surgeons at the Forbes Hospital Trauma ... are exploring an innovative use of Google Glass technology, ... (VIZR), to assist in the care of critically injured ... wearable technology with an optical head-mounted display that provides ... the Internet via natural language voice commands. , Forbes’ ...
(Date:3/2/2015)... CA (PRWEB) March 02, 2015 Ticket ... tickets at the Hollywood Bowl . This popular site ... customer appreciation promo code JIMMY-BUFFETT-2015 for added savings. , ... their favorite performer will be headlining at the Hollywood ... concert will be on Thursday, October 22nd and it ...
(Date:3/2/2015)... Doctors in Novara, Italy have found ... of outcomes for people with mesothelioma than other clinical ... the new study on the Surviving Mesothelioma website. ... Eastern Piedmont followed the cases of 172 mesothelioma ... lung fluid. , “Persistent lung expansion after pleural ...
(Date:3/2/2015)... MN (PRWEB) March 02, 2015 ... temperature calibration for Secondary Standard Platinum Resistance ... in 5 business days or less . . ... NVLAP ® Accredited (Lab Code 200706-0), ISO ... traceability. Temperature range is -196°C to 500°C, ...
(Date:3/2/2015)... The minimally invasive surgical instruments market is expected ... reach $14,133.0 million by 2019 from $10,526.2 million ... of minimally invasive surgeries over traditional open surgeries, ... and increasing number of surgical procedures among the ... surgical instruments market. , For More Details @ ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2
(Date:3/2/2015)... March 2, 2015   Polymedco is committed to supporting ... CRC Awareness Month, we are offering all existing customers ... , Posters – to be hung in patient ... Patient Brochures with Stand – to be placed in ... to be put on/in patient charts as a reminder ...
(Date:3/2/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... developing and commercializing proven cancer therapies in new ... a Notice of Allowance from the U.S. Patent ... 13/817,096 entitled, " Compositions and methods to improve ...
(Date:3/2/2015)... , March 2, 2015  Sarnova, parent company ... of the new www.tri-anim.com website, continuing ... healthcare distributor of respiratory, anesthesia and other critical ... The site has many new features ... making online shopping and ordering easier and more ...
Breaking Medicine Technology:Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3
Cached News: